The Active Revolution: The adoption of active refrigerated containers is accelerating in international pharmaceutical transportation. These advanced containers actively regulate temperature throughout the journey, helping to prevent temperature fluctuations that could compromise product quality.
Managing Temperature Excursions: For some pharmaceutical products, even a brief temperature excursion can have serious consequences. In certain cases, deviating from the required 2°C to 8°C range for just a few minutes may affect product integrity and efficacy.
A Strategic Approach for Japan: Given the increasingly frequent heatwaves and extreme weather conditions experienced in Japan and other regions in recent years, robust temperature management at airports is essential. Equally important is the development of a nationwide ground transportation network capable of maintaining strict temperature control across the country.
Strategic Growth: Looking beyond 2026, the adoption of Cold Chain 2.0 will become a critical component of pharmaceutical logistics and supply chain management.
Transporting biologics is fundamentally a race against time and temperature, requiring exceptionally stringent control throughout the supply chain. Even minor delays can result in losses worth hundreds of millions of yen and have significant consequences for patients and other stakeholders who rely on these products. This article explains why Cold Chain 2.0 will be essential in 2026 and beyond, leveraging active packaging technologies and real-time data to ensure the safe, secure, and reliable transportation of healthcare products.
In pharmaceutical cold chain logistics, choosing the right packaging solution is critical to maintaining product integrity throughout transportation. Broadly speaking, cold chain packaging falls into two categories: passive packaging and active packaging.
Passive packaging relies on high-performance insulation materials and refrigerants such as gel packs or dry ice to maintain the required temperature for a predetermined period of time. Active packaging, on the other hand, uses mechanical or electrical cooling systems, effectively functioning as a mobile refrigerated unit throughout the shipment journey.
At DHL, we help customers select the most suitable cold chain technology based on their specific transportation routes, transit times, and product requirements.
Feature | Passive Packaging | Active Packaging |
|---|---|---|
Cooling Method | Gel packs, dry ice, or Phase Change Materials (PCM) | Electric compressor systems or dry ice-powered fan |
Typical Hold Time | Up to approximately 96 hours | Potentially unlimited with continuous power supply and operational support |
Environmental Control | Static (shields against external heat) | Dynamic (continually adjusts to ambient temperature) |
Best Use Case | Small parcels and stable vaccines | Large pallets, high-value biologics, cell and gene therapies, and other sensitive pharmaceuticals |
Because active solutions can more consistently maintain a predefined temperature range, they are particularly effective for long-haul international air freight and complex pharmaceutical supply chains. This is especially important for biologics and other temperature-sensitive healthcare products, where even a brief temperature excursion may impact product quality. However, active packaging does come with higher associated costs, including rental fees, specialized handling requirements, and operational support. For this reason, organizations must carefully weigh risk, cost, transit time, and product value when selecting the most appropriate cold chain solution. As global pharmaceutical supply chains continue to grow in complexity, active packaging is becoming an increasingly important tool for ensuring the safe, compliant, and reliable transportation of healthcare products worldwide.
Regulators want a full data trail for every life sciences shipment. You can't just rely on a green light when the box arrives. You need a digital record of every single minute to satisfy your Quality Assurance teams.
DHL can provide enhanced visibility using SmartSensor technology. These IoT loggers show temperature, light exposure, and physical shock during transport. If a box is opened or dropped, we'll know exactly when and where it happened. This is a core part of modern vaccine logistics.
The WHO defines a temperature excursion as any deviation from the allowed range. In 2026, standards require immediate digital reporting of these events. This helps you make Go or No-Go decisions faster. It also reduces the time your inventory stays in quarantine.
Industry experts report that most temperature failures happen right on the tarmac, where shipments are temporarily exposed during aircraft loading and unloading operations.
This challenge has become increasingly significant in Japan, where summers have grown hotter in recent years. High ambient temperatures and heat radiating from asphalt surfaces can quickly exceed the thermal protection limits of passive packaging solutions.
Climate risks vary throughout the year:
Elevated humidity levels can reduce the effectiveness of cardboard-based insulation materials and packaging components.
Japan's intense summer sunlight and prolonged high temperatures require additional protective measures, including shading and heat mitigation strategies, to prevent temperature-sensitive products from overheating.
Major international gateways such as Narita International Airport and Kansai International Airport are equipped with sophisticated logistics infrastructure. The challenge in Japan is often the "middle mile" between big airports and regional clinics, hospitals, or healthcare facilities.
Temperature-controlled ground transportation forms the backbone of Japan's inland cold chain network. To maintain product integrity until final delivery, organizations need logistics partners capable of managing the entire journey under a consistent temperature-controlled environment.
DHL Medical Express combines DHL's global air network with specialized domestic transportation capabilities to help ensure vaccines and other healthcare products can be delivered efficiently, even to remote clinics and regional healthcare facilities.
Leveraging DHL's extensive domestic service center network, we provide fast door-to-door GDP compliant healthcare transportation designed to support timely pharmaceutical delivery across Japan.
A sensor alert lets you save the shipment before the product is damaged. Our Global Control Towers watch your shipments 24/7 to catch these drifts as they happen. If a sensor reports a temperature spike, our team starts an intervention protocol immediately.
Examples of corrective actions include:
To ensure rapid and consistent responses, DHL develops Standard Operating Procedures (SOPs) tailored to each shipment and temperature-control requirement.
Potentially affected products are immediately transferred to a secure refrigerated environment upon arrival.
Data logs are downloaded from SmartSensor devices to determine the duration and extent of any temperature excursion.
Shipment data is provided to Quality Assurance (QA) teams for formal evaluation and product disposition decisions.
A comprehensive investigation is conducted to identify the underlying cause of the temperature excursion and prevent future occurrences.
Active temperature management and real-time monitoring are more than investments in logistics capabilities. They are investments in your brand, product quality, and patient outcomes.
In the healthcare sector, logistics failures can lead to consequences that extend far beyond financial losses. They can jeopardize clinical trial opportunities and delay life-saving treatments for patients waiting for critical therapies. Pharmaceutical imports and exports are also subject to stringent regulatory and compliance requirements, making reliable cold chain management essential.
Complying with the strict regulations of Japan Customs (税関), particularly laws on customs valuation, is paramount. Improper valuation can lead to full audits and shipment delays. Partnering with an expert 通関業者 (Customs Broker) who ensures commercial invoices use the correct transaction value methodology is critical to avoid these risks.
We've invested 2 billion euros into expanding and strengthening the DHL Health Logistics network. We're here to provide the specialist handling and white-glove service that these new biologics and advanced healthcare products demand.
Your logistics should be just as precise as the science you're working on.
Contact us for a conversation on the state of cold chain 2.0 biologics in 2026. Let's work together to make sure your products stay stable from the lab to the patient.
It refers to the next generation of life sciences logistics. It uses active cooling and IoT sensors to provide real-time visibility. This shift ensures high-value biologics and vaccines stay within their required temperature range for the whole journey.
Passive packaging uses insulation and gel packs to keep items cool for a set time. Active packaging uses mechanical systems and batteries to act as a portable refrigerator. Active systems are safer for high-value biologics in extreme climates.
We use a dedicated network that combines our global aircraft with local refrigerated transport. This service includes priority handling and customs clearance to ensure vaccines reach clinics quickly.
Good Distribution Practice (GDP) is a set of standards that ensures the quality of medicine is maintained during transport. It's a mandatory requirement for any provider handling life sciences products.
Share
